Judith A. Finlay

1.5k total citations
30 papers, 1.2k citations indexed

About

Judith A. Finlay is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Judith A. Finlay has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Judith A. Finlay's work include Prostate Cancer Treatment and Research (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Judith A. Finlay is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Judith A. Finlay collaborates with scholars based in United States, Sweden and Netherlands. Judith A. Finlay's co-authors include Harry G. Rittenhouse, Alan W. Partin, Stephen D. Mikolajczyk, Robert L. Wolfert, Hans Lilja, Robert McCormack, Tongliang Wang, Joseph E. Oesterling, George G. Klee and Daniel W. Chan and has published in prestigious journals such as The EMBO Journal, Blood and Biochemistry.

In The Last Decade

Judith A. Finlay

29 papers receiving 1.2k citations

Peers

Judith A. Finlay
Rute B. Marques Netherlands
Carlos García-Echeverría Switzerland
Kevin Yee United States
Sunita R. Setlur United States
M Giai Italy
Mirosław Majewski Poland
Thea M. Vroom Netherlands
David Clouston Australia
Haruhiro Yukiue Japan
Ellen Schlette United States
Rute B. Marques Netherlands
Judith A. Finlay
Citations per year, relative to Judith A. Finlay Judith A. Finlay (= 1×) peers Rute B. Marques

Countries citing papers authored by Judith A. Finlay

Since Specialization
Citations

This map shows the geographic impact of Judith A. Finlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A. Finlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A. Finlay more than expected).

Fields of papers citing papers by Judith A. Finlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A. Finlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A. Finlay. The network helps show where Judith A. Finlay may publish in the future.

Co-authorship network of co-authors of Judith A. Finlay

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A. Finlay. A scholar is included among the top collaborators of Judith A. Finlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A. Finlay. Judith A. Finlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jenkins, Valerie, May Teoh, David Bloomfield, et al.. (2023). Patients’ views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer. Supportive Care in Cancer. 31(11). 658–658.
2.
Finlay, Judith A. & Alan H.B. Wu. (2014). Biological variation of immunoglobulin heavy chain-light chain pairs in serum. Clinica Chimica Acta. 436. 68–71. 5 indexed citations
3.
Martín, Benjamín, et al.. (2004). Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA). Prostate Cancer and Prostatic Diseases. 7(2). 132–137. 22 indexed citations
4.
Finlay, Judith A., John Day, Cindy L. Evans, et al.. (2001). Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2. Clinical Chemistry. 47(7). 1218–1224. 18 indexed citations
5.
Saedi, Mohammad S., Harry G. Rittenhouse, Judith A. Finlay, Stephen D. Mikolajczyk, & Alan W. Partin. (1999). The prostate-localized kallikreins: Prostate specific antigen and human kallikrein 2. 22(4). 371–375. 1 indexed citations
6.
Partin, Alan W., William J. Catàlona, Judith A. Finlay, et al.. (1999). Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology. 54(5). 839–845. 98 indexed citations
7.
8.
Finlay, Judith A., John Day, & Harry G. Rittenhouse. (1999). Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1. Urology. 53(4). 746–751. 11 indexed citations
9.
Lin, Daniel W., William J. Ellis, Paul H. Lange, et al.. (1999). SERUM HUMAN GLANDULAR KALLIKREIN (hK2) IN METASTATIC PROSTATE CANCER. The Journal of Urology. 96–96. 2 indexed citations
10.
Klee, George G., Marcia K. Goodmanson, Steven J. Jacobsen, et al.. (1999). Highly Sensitive Automated Chemiluminometric Assay for Measuring Free Human Glandular Kallikrein-2. Clinical Chemistry. 45(6). 800–806. 40 indexed citations
11.
Rittenhouse, Harry G., Judith A. Finlay, Stephen D. Mikolajczyk, & Alan W. Partin. (1998). Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate. Critical Reviews in Clinical Laboratory Sciences. 35(4). 275–368. 262 indexed citations
12.
13.
Grauer, Lana S., et al.. (1998). Detection of Human Glandular Kallikrein, hK2, as Its Precursor Form and in Complex With Protease Inhibitors in Prostate Carcinoma Serum. Journal of Andrology. 19(4). 407–411. 41 indexed citations
14.
Pannek, Jürgen, Harry G. Rittenhouse, Cindy L. Evans, et al.. (1997). Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology. 50(5). 715–721. 33 indexed citations
15.
Charlesworth, M. Cristine, Charles YF Young, George G. Klee, et al.. (1997). Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Urology. 49(3). 487–493. 52 indexed citations
16.
Grauer, Lana S., M. Cristine Charlesworth, Mohammad S. Saedi, et al.. (1996). Identification of Human Glandular Kallikrein hK2 From LNCaP Cells. Journal of Andrology. 17(4). 353–359. 25 indexed citations
17.
Finlay, Judith A., et al.. (1995). Outcome prediction in open bite cases. European Journal of Orthodontics. 17(6). 519–523. 6 indexed citations
18.
McCormack, Robert, Tongliang Wang, Harry G. Rittenhouse, et al.. (1995). Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology. 45(5). 729–744. 259 indexed citations
19.
Finlay, Judith A. & Andrew Richardson. (1990). An investigation into the age of cessation of endocranial growth using the techniques of logetronic copying and photosubtraction. Annals of Human Biology. 17(4). 289–296. 1 indexed citations
20.
Finlay, Judith A. & Hector F. DeLuca. (1988). Purification and properties of an 18-kilodalton, 1,25-dihydroxyvitamin D3-modulated protein from embryonic chick intestine. Biochemistry. 27(9). 3381–3387. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rute B. Marques Breakdown of academic impact, for papers by Carlos García-Echeverría Breakdown of academic impact, for papers by Kevin Yee Breakdown of academic impact, for papers by Sunita R. Setlur Breakdown of academic impact, for papers by M Giai Breakdown of academic impact, for papers by Mirosław Majewski Breakdown of academic impact, for papers by Thea M. Vroom Breakdown of academic impact, for papers by David Clouston Breakdown of academic impact, for papers by Haruhiro Yukiue Breakdown of academic impact, for papers by Ellen Schlette
Rankless by CCL
2026